Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 6Breast 2Thoracic 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × polyphenon E × Breast × Clear all
NCT01060345 2020-04-09

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

University of Chicago

Phase 2 Terminated
20 enrolled 5 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT00676793 2017-09-21

A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression

Louisiana State University Health Sciences Center Shreveport

Phase 2 Completed
32 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡